Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study

被引：49
|
作者：
Stopeck, A. [1 ]
Body, J. J. [2 ]
Fujiwara, Y. [3 ]
Lipton, A. [4 ]
Steger, G. G. [5 ]
Viniegra, M. [6 ]
Fan, M. [7 ]
Braun, A. [8 ]
Dansey, R. [8 ]
Jun, S. [8 ]
机构：
[1] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA
[2] Univ Libre Bruxelles, CHU Brugmann, Brussels, Belgium
[3] Natl Canc Ctr, Tokyo, Japan
[4] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[5] Med Univ Vienna, Vienna, Austria
[6] Corp Med Gen San Martin, San Martin, Argentina
[7] Amgen Inc, Biostat & Epidemiol, Thousand Oaks, CA 91320 USA
[8] Amgen Inc, Hematol Oncol, Thousand Oaks, CA 91320 USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(09)72028-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2 / 3
页数：2
相关论文
共 50 条
  • [1] A double-blind randomized Study of Denosumab compared with Zoledronic acid for Treatment of Bone metastases in Patients with Breast cancer: Results of a randomized phase 3 study.
    Steger, G.
    Stopeck, A.
    Body, J. J.
    Fujiwara, Y.
    Lipton, A.
    Viniegra, M.
    Fan, M.
    Braun, A.
    Dansey, R.
    Jun, S.
    [J]. ONKOLOGIE, 2010, 33 : 10 - 10
  • [2] Effect of Denosumab Versus Zoledronic Acid Treatment in Patients with Breast Cancer and Bone Metastases: Results from the Extended Blinded Treatment Phase
    Stopeck, A.
    Martin, M.
    Ritchie, D.
    Body, J-J
    Paterson, A.
    Viniegra, M.
    Jassem, J.
    Takano, T.
    Van Poznak, C.
    Bourgeois, H.
    Fan, M.
    Dansey, R.
    Braun, A.
    [J]. CANCER RESEARCH, 2010, 70
  • [3] EFFECT OF DENOSUMAB VERSUS ZOLEDRONIC ACID ON OVERALL SURVIVAL IN PATIENTS WITH LUNG CANCER AND BONE METASTASES: RESULTS FROM A RANDOMIZED PHASE 3 STUDY
    Scagliotti, G.
    Woll, P.
    Manegold, C.
    Solal-Celigny, P.
    Lipton, L.
    Garcia-Saenz, J. A.
    Pereira, J. R.
    Prabhash, K.
    Ciuleanu, T.
    Jacobs, I.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S61 - S62
  • [4] Acute-Phase Reactions Following Treatment with Zoledronic Acid or Denosumab: Results from a Randomized, Controlled Phase 3 Study in Patients with Breast Cancer and Bone Metastases
    Stopeck, A. T.
    Lipton, A. A.
    Campbell-Baird, C.
    von Moos, R.
    Fan, M.
    Haddock, B.
    Braun, A.
    [J]. CANCER RESEARCH, 2010, 70
  • [5] Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases
    Body, Jean-Jacques
    Stopeck, Alison
    Fujiwara, Yasuhiro
    Lipton', Allan
    Steger, Guenther
    Viniegra, Maria
    Fan, Michelle
    Dansey, Roger
    Susie, Jun
    Ada, Braun
    [J]. BONE, 2010, 46 : S36 - S37
  • [6] Breast cancer bone metastases: denosumab or zoledronic acid?
    Gabri van der Pluijm
    [J]. Nature Reviews Endocrinology, 2011, 7 : 134 - 135
  • [7] CANCER Breast cancer bone metastases: denosumab or zoledronic acid?
    van der Pluijm, Gabri
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (03) : 134 - 135
  • [8] Denosumab versus zoledronic acid in patients with bone metastases from castration-resistant prostate cancer: Results from a phase 3 randomized trial
    Brown, J.
    Carducci, M.
    Fizazi, K.
    Smith, M.
    Damiao, Damiao R.
    Karsh, L.
    Milecki, P.
    Wang, H.
    Dansey, R.
    Goessl, C.
    [J]. BONE, 2011, 48 (01) : S16 - S16
  • [9] Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
    Stopeck, Alison T.
    Lipton, Allan
    Body, Jean-Jacques
    Steger, Guenther G.
    Tonkin, Katia
    de Boer, Richard H.
    Lichinitser, Mikhail
    Fujiwara, Yasuhiro
    Yardley, Denise A.
    Viniegra, Maria
    Fan, Michelle
    Jiang, Qi
    Dansey, Roger
    Jun, Susie
    Braun, Ada
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (35) : 5132 - 5139
  • [10] A double-blind, randomized study of denosumab versus zoledronic acid for the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma
    Henry, D.
    von Moos, R.
    Vadhan-Raj, S.
    Hungria, V.
    Spencer, A.
    Hirsh, V.
    Wang, J.
    Jun, S.
    Yeh, H.
    Dansey, R.
    [J]. EJC SUPPLEMENTS, 2009, 7 (03): : 12 - 12
12345